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SUMMARY. The aim of this study was to evaluate the in vivo behavior of matrix tablets formulated with
ketoprofen as a model drug after oral administrations in healthy Malaysian male volunteers and to com-
pare its rate and extent of absorption with the commercially available tablet Apo-Keto SR® as a reference
product. The test formulation containing 20 % HPC (GXF) as release retardant was selected in this re-
gards. The bioequivalence study was conducted according to a single dose, randomized, 2-treatment, 2-se-
quence, 2-period crossover study design on six healthy non-smoking Malaysian adult male volunteers.
Plasma concentrations of ketoprofen were determined by a high-performance liquid chromatographic
method with UV detection. The pharmacokinetic parameters, Tmax, Cmax, AUC0–∞, Ke, and T1/2 were de-
termined. The 90 % confidence intervals of the mean values for the test/reference ratios were 96.89-107.03
% for AUC0–∞ and 99.64-104.62 % for Cmax, respectively. The results of this study suggest that the two
preparations, the test formulation of ketoprofen 200 mg tablets were bioequivalent to the marketed refer-
ence tablet of Apo-Keto SR® 200 mg in these healthy Malaysian male volunteers. However, this study re-
sults are to be further confirmed by carrying out a pivotal biostudy using more number of subjects.
